PRP, Red Light Therapy, Nutrafol, and More: Which Hair Loss Treatments Actually Work?

If you’ve been researching treatments for thinning hair, you’ve probably encountered a long list of options.

PRP injections. Microneedling. Red light therapy. Nutrafol. Biotin. Rosemary oil. And increasingly, treatments involving stem cells or exosomes.

Many promise thicker hair, less shedding, or renewed growth. Some are expensive, some require repeated procedures, and others can be purchased online without seeing a physician.

But these treatments aren’t supported by the same quality of evidence.

The important distinction isn’t simply whether a treatment has a study showing positive results. It’s how strong that evidence is, what kind of hair loss was studied, and whether the potential benefit justifies the cost and risk.

Why does the type of hair loss matter?

Before comparing treatments, it’s important to understand that hair loss isn’t one condition.

Androgenetic alopecia, also called female-pattern or male-pattern hair loss, involves gradual changes in hair follicles that produce progressively thinner hairs.

Telogen effluvium causes increased shedding, often following illness, significant weight loss, childbirth, or another physical stressor.

Other conditions, including alopecia areata and inflammatory or scarring alopecias, have different causes and may require specialized treatment.

Most research on PRP, microneedling, and red light therapy focuses on androgenetic alopecia.

A treatment that improves hair density in pattern hair loss won’t necessarily help someone experiencing temporary shedding or a scarring scalp disorder.

This distinction is particularly important when evaluating products marketed broadly for “hair loss” without specifying which condition they’re intended to treat.

Does PRP work for hair loss?

Platelet-rich plasma (PRP) is one of the more extensively studied procedural treatments for pattern hair loss.

PRP is prepared by drawing a patient’s blood and processing it to concentrate platelets. The resulting preparation is injected into areas of thinning scalp hair.

Platelets contain growth factors involved in tissue repair and cell signaling, which may influence hair follicle activity.

What does the research show?

Multiple randomized trials and systematic reviews suggest that PRP can improve hair density in some patients with androgenetic alopecia.

A 2023 systematic review and meta-analysis of clinical trials found that PRP improved several measures of hair growth, although results varied across studies.

A 2024 systematic review focused on female hair loss also reported improvements in hair-growth outcomes following PRP treatment.

PRP has promising evidence for pattern hair loss, but its effectiveness is not equally established across treatment protocols.

What are the limitations?

PRP isn’t one standardized treatment.

Clinics may use different blood-processing methods, platelet concentrations, injection techniques, treatment intervals, and maintenance schedules.

That makes it difficult to predict how closely the results from a clinical trial will apply to a particular clinic’s treatment.

PRP also involves repeated office procedures, potential discomfort, and out-of-pocket costs. Side effects can include temporary scalp pain, swelling, bruising, or bleeding.

PRP works by stimulating existing hair follicles rather than creating new ones. It may be more useful in earlier stages of pattern hair loss, when follicles are still capable of producing hair, than in areas with longstanding, extensive follicular loss.

Initial treatment commonly involves a series of injections, and maintenance sessions may be needed to sustain improvement. PRP isn’t a cure for androgenetic alopecia.

Some patients may benefit, but meaningful regrowth isn’t guaranteed.

Our assessment: PRP is a reasonable option to discuss with a dermatologist for selected patients with pattern hair loss, particularly when considering additional treatment beyond established medications. It has genuine clinical evidence, but questions remain about the optimal protocol, maintenance schedule, and long-term benefits.

Does microneedling stimulate hair growth?

Microneedling uses a device containing small needles to create controlled punctures in the scalp.

The proposed mechanisms include stimulating wound-healing pathways and growth-factor signaling. Microneedling may also influence the penetration of medications applied to the scalp.

What does the research show?

Several studies have evaluated microneedling in combination with topical minoxidil.

A 2023 systematic review and meta-analysis of eight randomized trials found that combining microneedling with topical minoxidil improved total hair counts compared with minoxidil alone, although hair diameter did not significantly improve.

A subsequent 2025 meta-analysis of 12 randomized trials involving 631 patients also reported greater improvements in hair counts with combination treatment.

However, the studies varied substantially in their treatment methods and results.

Importantly, a 2026 randomized trial involving 245 women found that adding microneedling every two or four weeks to topical minoxidil 2% did not provide additional benefit over minoxidil alone after 24 weeks.

This larger trial introduces meaningful uncertainty about how consistently microneedling improves results.

The evidence for microneedling as an addition to minoxidil is promising but inconsistent. Evidence supporting microneedling as a standalone treatment is more limited.

Can you do microneedling at home?

At-home dermarollers and microneedling devices are widely available, but that doesn’t mean every device or technique is appropriate for the scalp.

Potential complications include irritation, infection, bleeding, and injury to the skin. Microneedling may worsen certain inflammatory or scarring scalp conditions.

It can also alter absorption of topical medications. Applying minoxidil immediately after a procedure that disrupts the skin barrier may increase irritation or systemic absorption.

Studies have used different needle depths, and deeper treatment has not consistently produced better results. One comparison found greater improvement with 0.6 mm than with 1.2 mm microneedling when combined with minoxidil.

There is no universally established at-home protocol for needle depth, treatment frequency, or timing of topical medications.

Our assessment: Microneedling is a promising but inconsistently supported adjunct to established treatments, particularly topical minoxidil. The evidence doesn’t justify assuming that more aggressive or more frequent microneedling produces better results. Discussing it with a dermatologist is preferable to experimenting with deeper at-home procedures.

Does red light therapy really work for hair loss?

Red light therapy, also called low-level light therapy (LLLT) or photobiomodulation, uses specific wavelengths of light to stimulate biological activity in the scalp.

Products include laser combs, caps, helmets, and LED devices.

Unlike PRP or microneedling, many light-based treatments can be used at home.

What does the research show?

Red light therapy has a meaningful evidence base for androgenetic alopecia.

A systematic review and meta-analysis published in 2025 evaluated 38 studies involving 3,098 participants across several forms of hair loss.

Most participants had androgenetic alopecia, and the analysis found improvements in hair density compared with placebo or sham treatment.

However, results varied substantially across studies, and evidence for other forms of hair loss was much more limited.

Research on combining light therapy with minoxidil has also been encouraging. A 2025 meta-analysis found improvements in hair density, hair diameter, and patient satisfaction with combination treatment compared with minoxidil alone, although not every measured outcome showed a significant benefit.

Are all laser caps equally effective?

No.

Devices differ in wavelength, power, light source, treatment duration, and the amount of scalp they cover.

Results from one studied device shouldn’t automatically be assumed to apply to every red light cap or helmet sold online.

Some hair-growth devices have FDA clearance, but FDA clearance of a device is not the same as FDA approval of a medication, and it doesn’t mean that every advertised benefit has been demonstrated in large clinical trials.

Industry sponsorship is another consideration. Some device trials, including research involving HairMax products, have had manufacturer involvement. That doesn’t invalidate their findings, but independent replication strengthens confidence in treatment claims.

These devices also require consistent use over months, and the financial investment can be substantial.

Our assessment: Red light therapy is a legitimate, noninvasive option for selected patients with pattern hair loss. It may be appealing to people who prefer to avoid additional medication, but expectations should remain realistic, and product-specific evidence matters.

Does Nutrafol actually work?

Nutrafol is a commercially marketed hair-growth supplement containing combinations of botanical extracts, vitamins, minerals, and other ingredients.

Unlike medications that target specific biological pathways, these products are generally marketed around multiple potential contributors to hair thinning, including nutrition, stress, and hormonal changes.

Some Nutrafol formulations contain saw palmetto, a botanical ingredient with potential 5-alpha-reductase-inhibiting activity. This matters because ingredients marketed as natural can still have biological effects, including potential implications during pregnancy.

What does the research show?

Nutrafol has been evaluated in randomized, placebo-controlled clinical trials.

A six-month trial published in 2018 enrolled 40 women with self-perceived thinning hair. Participants taking the supplement showed improvements in certain measured hair-growth outcomes compared with placebo.

A subsequent trial involving 70 perimenopausal, menopausal, and postmenopausal women also reported improvements in hair counts and shedding over six months.

A 2023 systematic review in JAMA Dermatology identified Nutrafol among the nutritional supplements with relatively stronger evidence of potential benefit for hair loss.

These are positive findings, and they shouldn’t be dismissed simply because the treatment is a supplement.

However, the trials were relatively small, involved selected populations, and included manufacturer funding or other industry involvement.

Participants were enrolled based on self-perceived thinning, and baseline nutritional status wasn’t comprehensively assessed. Some participants may also have had temporary forms of shedding that would improve naturally.

The trials did not consistently use the full range of standardized trichoscopic measures commonly employed in larger alopecia treatment studies.

Larger independent studies would help establish how reliably these results translate into meaningful benefits for patients.

Is Nutrafol as effective as minoxidil?

There isn’t sufficient high-quality comparative evidence to conclude that Nutrafol is equivalent or superior to established treatments such as minoxidil.

A statistically significant improvement compared with placebo doesn’t establish that a product works as well as a medication tested in a much larger body of research.

It also doesn’t establish that every ingredient in a combination supplement contributes to the observed benefit.

Another consideration is cost. Supplements are typically purchased continuously, and long-term benefit after discontinuation is not well established.

Because supplements contain biologically active ingredients, they can also have side effects, interact with medications, or be inappropriate during pregnancy or with certain medical conditions.

Reported gastrointestinal side effects include nausea, bloating, and diarrhea.

Products containing saw palmetto deserve particular caution during pregnancy or when pregnancy is possible because of potential effects on androgen metabolism. Patients should review the specific formulation and ingredients with their clinician rather than assuming that a supplement is safe because it’s marketed as natural.

Our assessment: Nutrafol has some encouraging clinical evidence, but the research is not yet strong enough to place it on equal footing with established treatments for androgenetic alopecia. It’s reasonable to discuss as an optional adjunct, rather than a necessary component of hair-loss care.

What about biotin, collagen, and other hair-growth supplements?

Biotin, collagen, zinc, iron, and other nutrients are frequently marketed for thicker, healthier hair.

Nutrition does matter for hair growth.

But there’s a difference between correcting a nutritional deficiency and taking extra nutrients when your levels are already adequate.

Biotin

Biotin deficiency can cause hair loss, but true deficiency is uncommon.

For people without a deficiency, evidence that high-dose biotin supplements improve hair growth is limited.

High-dose biotin can also interfere with laboratory testing, including certain thyroid tests and cardiac troponin assays.

Iron and zinc

Iron or zinc deficiency may contribute to hair loss in some patients.

When a deficiency is present, correcting it can be an important part of treatment.

But routinely taking high doses without evidence of deficiency isn’t recommended. Excess supplementation can cause adverse effects, and excessive zinc intake can contribute to copper deficiency.

Collagen

Collagen supplements are widely promoted for skin and hair health, but convincing clinical evidence that they meaningfully treat androgenetic alopecia is lacking.

Our assessment: Evaluate nutritional deficiencies when clinically indicated, and correct them when present. More supplements do not necessarily mean more hair growth.

Does rosemary oil work as well as minoxidil?

Rosemary oil has become popular as a more “natural” alternative to minoxidil.

Much of the attention comes from a 2015 randomized trial comparing rosemary oil with topical minoxidil 2% in 100 men with androgenetic alopecia.

After six months, both groups showed improvements in hair counts, with no statistically significant difference between the groups.

That finding is interesting, but it has an important limitation.

A study finding no statistically significant difference does not establish that two treatments are equally effective.

The trial was relatively small, included men only, did not include a placebo group, and compared rosemary oil with 2% minoxidil rather than every commonly used minoxidil regimen.

Its results therefore cannot automatically be generalized to women with female-pattern hair loss.

There isn’t a comparable body of high-quality evidence establishing rosemary oil as a replacement for minoxidil.

Essential oils can also cause irritation or allergic contact dermatitis, particularly when applied without appropriate dilution.

Our assessment: Rosemary oil has preliminary evidence, but claims that it is proven to work just as well as minoxidil go beyond what the research establishes.

What about stem cells and exosome treatments for hair loss?

Some clinics now advertise stem cell treatments, exosome injections, or other regenerative procedures for hair growth.

These approaches are scientifically interesting, but the marketing has moved ahead of the clinical evidence.

Early studies are exploring whether cell-derived products or signaling molecules might influence hair follicle growth.

However, treatment preparations, manufacturing methods, dosing, and safety standards vary substantially.

The FDA has warned consumers about unapproved regenerative medicine products and has stated that there are no FDA-approved exosome products.

Our assessment: These treatments remain investigational for hair loss. Patients should be particularly cautious about expensive procedures marketed with claims of dramatic regeneration or permanent results.

How do these treatments compare?

The evidence is not equally strong across these options.

These categories aren’t interchangeable. A device, an injection procedure, and a nutritional supplement may each have a different role depending on the diagnosis and the patient’s goals.

Should you try these treatments before prescription medication?

Not necessarily.

For androgenetic alopecia, treatments such as topical minoxidil have a more established evidence base than most supplements and newer procedures.

Other medications, including oral minoxidil, finasteride, dutasteride, and spironolactone, may be appropriate for selected patients depending on their medical history and the type of hair loss.

That doesn’t mean everyone needs medication, or that non-medication treatments have no value.

Some patients prefer a noninvasive device. Others are interested in adding PRP or microneedling to an existing treatment plan.

But an expensive treatment shouldn’t automatically be considered better simply because it’s newer, more technologically sophisticated, or described as natural.

It’s also worth asking whether a treatment is intended to replace established care or supplement it.

If your hair loss is caused by a nutritional deficiency, inflammatory condition, or temporary shedding, the most useful intervention may be addressing the underlying cause rather than adding a hair-growth procedure.

How can you tell whether a hair-loss treatment is worth trying?

Before investing in a treatment, consider a few questions:

• What type of hair loss was studied? Results in androgenetic alopecia may not apply to other diagnoses.
• Was the treatment compared with a placebo, sham device, or established therapy? Different study designs answer different questions.
• How many people were studied, and for how long? Small, short trials can miss important limitations.
• Were outcomes measured objectively? Hair counts and standardized photographs are more informative than testimonials alone.
• Was the research independently funded? Industry involvement doesn’t invalidate a study, but independent replication strengthens confidence.
• What will ongoing treatment require? Cost, maintenance visits, daily use, and long-term adherence matter.

A treatment can have promising research behind it without being the best choice for every patient.

And a treatment can be marketed very convincingly without having much clinical evidence at all.